TICKERNERD
Menu
BHSTBHSTConsumer Defensive · Packaged Foods

BHST Stock Forecast: BioHarvest Sciences, Inc. Price Predictions for 2026-2027

Last close, 3 Aug 2026
$2.16
0.00% on the day

The 4 Wall Street analysts covering BioHarvest Sciences, Inc. hold a median 12-month price target of $13 — +501.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 41 of 100 as at 1 Aug 2026 — in the lower half.

Market cap
$49.9M
Ticker Nerd rank
41 / 100
Median analyst target
$13
Analysts covering
4
Total return, dividends reinvested
1W
+6.4%
1M
−24.7%
YTD
−58.4%
1Y
−71.9%
From 52W high
−82.9%
From 52W low
+12.5%
$2
$13
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

BHST stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores BioHarvest Sciences, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
41 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
82
Quality
78
Volatility
72
Issuance
60
Growth
51
Value
48
Revisions
41
Accruals
19
Momentum
5

Size (82): Smaller than most of the companies we track.

Momentum (5): The shares have been drifting down relative to others.

The rank is the raw material. Whether the rules would actually own BioHarvest Sciences, Inc. — and when they’d sell — is the membership.

Wall Street

BHST stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on BHST, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0$5$10$15Oct 25Jan 26Apr 26Jul 26BHSTHigh $15Median $13Low $10

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says4 analysts
4 Buy0 Hold0 Sell
Low $10Median $13High $15

The green dot is the last close — the median target sits +501.9% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
19 Feb 2026Roth CapitalInitiatesBuy$10
8 Apr 2025HC Wainwright & Co.ReiteratesBuy—
18 Dec 2024Maxim GroupInitiatesBuy—
11 Dec 2024HC Wainwright & Co.ReiteratesBuy—
6 Dec 2024HC Wainwright & Co.InitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

BHST analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
3
Fundamentals

BioHarvest Sciences, Inc. (BHST) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−3.6×

Cheaper than 88% of US stocks

Price / sales
1.4×

Cheaper than 62% of US stocks

Price / book
2.1×

Cheaper than 44% of US stocks

EV / EBITDA
−8.2×

Cheaper than 83% of US stocks

Growth & margins
Revenue growth (YoY)
8.2%

Higher than 50% of US stocks

Earnings growth (YoY)
8.2%

Higher than 48% of US stocks

Gross margin
59.2%

Higher than 74% of US stocks

Operating margin
−21.6%

Higher than 22% of US stocks

Net margin
−32.5%

Higher than 13% of US stocks

Returns & dividend
Return on equity
−103.3%

Higher than 13% of US stocks

Return on assets
−9.9%

Higher than 27% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

BHST vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelPackaged Foods
CompanyMarket capTKN rank
BHSTBioHarvest Sciences, Inc.$49.9M
41
LSFLaird Superfood, Inc.$45.8M
30
HAINThe Hain Celestial Group, Inc.$45.4M
41
BRIDBridgford Foods Corp.$57.6M
33
BOFBranchOut Food, Inc.$59.9M
20
CLNNClene, Inc.$64.1M
38
LFVNLifeVantage Corp.$80.9M
76
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BHST appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest BHST news & analysis

BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference

Newsfile Corp · 29 July 2026neutral

BioHarvest Sciences announced that CEO Zaki Rakib will present at the Canaccord Genuity 46th Annual Growth Conference, scheduled for August 11-13, 2026 in Boston, and will also take part in one-on-one investor meetings on August 11-12.

Why it matters — Presenting at a major investment conference gives BioHarvest Sciences increased visibility among investors and the opportunity to engage directly with potential stakeholders.

BioHarvest Sciences to Report Second Quarter 2026 Financial Results on August 11, 2026

Newsfile Corp · 28 July 2026neutral

BioHarvest Sciences announced it will report its second quarter 2026 financial results before market open on August 11, 2026, followed by a conference call and webcast at 8:00 AM Eastern Time.

Why it matters — The announcement gives BHST shareholders and analysts a confirmed date and time to review the company's latest quarterly financial performance and operational update.

FAQ

Frequently asked questions about BHST stock

What is the BHST stock price forecast for 2026-2027?

The 4 Wall Street analysts covering BioHarvest Sciences, Inc. have a median 12-month price target of $13, with estimates ranging from $10 to $15. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is BHST stock a buy right now?

Of the 4 analysts covering BioHarvest Sciences, Inc., 4 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks BioHarvest Sciences, Inc. 41 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank BHST?

As at 1 Aug 2026, BioHarvest Sciences, Inc. ranks 41 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (82 of 100).

Will BHST stock go up?

No one can know that. What the data says: the median 12-month target from 4 analysts implies +501.9% from the last close, and Ticker Nerd's factor model ranks BioHarvest Sciences, Inc. 41 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the BHST stock forecast for 2030?

No analyst covering BioHarvest Sciences, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BHST are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $10 to $15 over the next 12 months.

How has BHST stock performed over the past year?

BioHarvest Sciences, Inc. returned -71.9% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does BioHarvest Sciences, Inc. do?

Bioharvest Sciences Inc. is a biotechnology company that focuses on developing innovative solutions for functional food and plant-based nutritional products.

What is the latest news on BHST?

The most recent item we track (Newsfile Corp, 29 July 2026): "BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference". BioHarvest Sciences announced that CEO Zaki Rakib will present at the Canaccord Genuity 46th Annual Growth Conference, scheduled for August 11-13, 2026 in Boston, and will also take part in one-on-one investor meetings on August 11-12.

Company

About BioHarvest Sciences, Inc.

Bioharvest Sciences Inc. is a biotechnology company that focuses on developing innovative solutions for functional food and plant-based nutritional products. The company’s primary function is to harness the benefits of natural compounds using a proprietary biofarming technology that allows for the production of plant-derived nutrients on an industrial scale. This technology is notable for producing bioactive compounds without the need for complex plant cultivation processes, making it a sustainable and scalable approach to nutraceutical production. Bioharvest Sciences Inc. impacts several industries, including health and wellness, alternative medicine, and environmental sustainability sectors. By offering products that are rich in essential nutrients and antioxidants, the company caters to the growing consumer demand for healthier lifestyles and plant-based alternatives. As part of its market significance, Bioharvest stands out for its potential to transform agricultural practices and improve access to high-quality nutritive compounds globally, thus contributing to the advancement of the food and nutrition industries.

CEO Dr. Zaki Rakib Ph.D. · 89 employees · Canada · https://www.bioharvest.com